Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nivolumab | 1.38 | 0.4 | 3831 | 98 | 9 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nivolumab | 0.69 | 0.7 | 7565 | 68 |
nivolumab melanoma | 0.1 | 0.6 | 5858 | 27 |
nivolumab side effects | 1.19 | 0.1 | 3468 | 99 |
nivolumab immunotherapy | 1.74 | 0.5 | 281 | 27 |
nivolumab package insert | 0.97 | 0.3 | 8281 | 62 |
nivolumab moa | 1.38 | 0.4 | 3619 | 3 |
nivolumab mechanism of action | 0.77 | 0.3 | 5256 | 69 |
nivolumab and ipilimumab | 1.84 | 0.7 | 78 | 85 |
nivolumab and pembrolizumab | 1.33 | 0.9 | 3315 | 31 |
nivolumab opdivo | 0.85 | 1 | 7214 | 82 |
nivolumab relatlimab | 0.93 | 0.5 | 9813 | 3 |
nivolumab brand name | 1.08 | 0.6 | 9190 | 69 |
nivolumab cost per dose | 0.7 | 0.4 | 86 | 14 |
nivolumab fda | 1.24 | 0.3 | 3832 | 46 |
nivolumab spc | 1.01 | 1 | 3583 | 80 |
nivolumab ema | 2 | 0.6 | 4502 | 18 |
nivolumab smpc | 1.67 | 0.9 | 6238 | 3 |
nivolumab nsclc | 0.08 | 0.7 | 1655 | 80 |
nivolumab and pembrolizumab combination | 1.4 | 0.8 | 2662 | 98 |
nivolumab and pembrolizumab for melanoma | 0.51 | 0.6 | 86 | 34 |
nivolumab injection | 1.41 | 0.7 | 4298 | 13 |
nivolumab side effects uptodate | 1.82 | 0.1 | 242 | 71 |
nivolumab rcp | 0.66 | 0.8 | 2658 | 11 |
nivolumab and pembrolizumab side effects | 1.12 | 0.1 | 3740 | 43 |
nivolumab biosimilar | 0.47 | 0.3 | 4879 | 54 |